BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND EP300, ENSG00000100393, 2033, RP1-85F18_1, p300 AND Treatment
57 results:

  • 1. Pathogenic Variants Associated with Epigenetic Control and the NOTCH Pathway Are Frequent in Classic Hodgkin lymphoma.
    Santisteban-Espejo A; Bernal-Florindo I; Montero-Pavon P; Perez-Requena J; Atienza-Cuevas L; Fernandez-Valle MDC; Villalba-Fernandez A; Garcia-Rojo M
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473705
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. BET inhibitors induce NF-κB and E2F downregulation in Hodgkin and Reed-Sternberg cells.
    Fernández S; Díaz E; Rita CG; Estévez M; Montalbán C; García JF
    Exp Cell Res; 2023 Sep; 430(2):113718. PubMed ID: 37468057
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.
    Jiménez-Ubieto A; Martín-Muñoz A; Poza M; Dorado S; García-Ortiz A; Revilla E; Sarandeses P; Ruiz-Heredia Y; Baumann T; Rodríguez A; Calbacho M; Sánchez PM; Pina JMS; García-Sancho AM; Figaredo G; Rufián L; Rodríguez M; Carneros L; Martínez-Laperche C; Bastos-Oreiro M; Wang C; Cedena MT; Rapado I; de Toledo P; Gallardo M; Valeri A; Ayala R; Martínez-López J; Barrio S
    Front Immunol; 2023; 14():1188818. PubMed ID: 37342332
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Efficient diagnosis of hematologic malignancies using bone marrow microscopic images: A method based on MultiPathGAN and MobileViTv2.
    Yang G; Qin Z; Mu J; Mao H; Mao H; Han M
    Comput Methods Programs Biomed; 2023 Jul; 237():107583. PubMed ID: 37167882
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinicopathological and molecular genetic characteristics of primary gastric follicular lymphoma.
    Kim H; Shin D; Son SM; Cho J; Kim JE; Kim Y; Jeon T; Ko YH
    Hum Pathol; 2023 Jun; 136():114-122. PubMed ID: 37054783
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Targeted therapy using larotrectinib and venetoclax for the relapsed/refractory T-cell acute lymphoblastic leukemia harboring a cryptic ETV6-NTRK3 fusion.
    Zhou K; Gong D; He C; Xiao M; Zhang M; Huang W
    Mol Carcinog; 2023 Jul; 62(7):899-906. PubMed ID: 37036164
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Genomic landscape of follicular lymphoma across a wide spectrum of clinical behaviors.
    Mozas P; López C; Grau M; Nadeu F; Clot G; Valle S; Kulis M; Navarro A; Ramis-Zaldivar JE; González-Farré B; Rivas-Delgado A; Rivero A; Frigola G; Balagué O; Giné E; Delgado J; Villamor N; Matutes E; Magnano L; García-Sanz R; Huet S; Russell RB; Campo E; López-Guillermo A; Beà S
    Hematol Oncol; 2023 Oct; 41(4):631-643. PubMed ID: 36994552
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The CRL4
    Tseng C; Han Y; Lv Z; Song Q; Wang K; Shen H; Chen Z
    J Mol Med (Berl); 2023 Feb; 101(1-2):171-181. PubMed ID: 36688959
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Diffuse large B-cell lymphoma and red cell autoimmunity: clinical role and pathogenesis.
    Coombes C; Horikawa K; Jain S; Jiang S; Lim JH; Saxena K; Shadbolt B; Smyth L; Tobin J; Talaulikar D
    Pathology; 2023 Feb; 55(1):104-112. PubMed ID: 36420560
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Mutational profiling of circulating tumor DNA and clinical characteristics in lymphoma: Based on next generation sequencing.
    Hou Y; Zi J; Liu S; Ge Q; Ge Z
    Mol Carcinog; 2023 Feb; 62(2):200-209. PubMed ID: 36300887
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Stilbene B10 induces apoptosis and tumor suppression in lymphoid Raji cells by BTK-mediated regulation of the KRAS/HDAC1/ep300/PEBP1 axis.
    Varier KM; Dan G; Liu W; Wu G; Xiao C; Lei H; Ling T; Jiang Y; Chen Y; Ben-David Y; Li Y; Zhang N; Gajendran B; Shen X
    Biomed Pharmacother; 2022 Dec; 156():113887. PubMed ID: 36274467
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Zinc finger protein 384 (
    Sudutan T; Erbilgin Y; Hatirnaz Ng O; Karaman S; Karakas Z; Kucukcankurt F; Celkan T; Timur C; Ozdemir GN; Hacısalihoglu S; Gelen SA; Sayitoğlu M
    Leuk Lymphoma; 2022 Dec; 63(12):2931-2939. PubMed ID: 35921545
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Inhibition of EZH2 transactivation function sensitizes solid tumors to genotoxic stress.
    Liao Y; Chen CH; Xiao T; de la Peña Avalos B; Dray EV; Cai C; Gao S; Shah N; Zhang Z; Feit A; Xue P; Liu Z; Yang M; Lee JH; Xu H; Li W; Mei S; Pierre RS; Shu S; Fei T; Duarte M; Zhao J; Bradner JE; Polyak K; Kantoff PW; Long H; Balk SP; Liu XS; Brown M; Xu K
    Proc Natl Acad Sci U S A; 2022 Jan; 119(3):. PubMed ID: 35031563
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. ZCL-082, a boron-containing compound, induces apoptosis of non-Hodgkin's lymphoma via targeting p90 ribosomal S6 kinase 1/NF-κB signaling pathway.
    Ma C; Liu M; Zhang J; Cai H; Wu Y; Zhang Y; Ji Y; Shan H; Zou Z; Yang L; Liu L; Xu H; Lei H; Liu C; Zhou L; Cao Y; Zhou H; Wu Y
    Chem Biol Interact; 2022 Jan; 351():109770. PubMed ID: 34861246
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Repressing MYC by targeting BET synergizes with selective inhibition of PI3Kα against B cell lymphoma.
    Chen ZQ; Cao ZR; Wang Y; Zhang X; Xu L; Wang YX; Chen Y; Yang CH; Ding J; Meng LH
    Cancer Lett; 2022 Jan; 524():206-218. PubMed ID: 34688842
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Worse outcome and distinct mutational pattern in follicular lymphoma with anti-HBc positivity.
    Fernández-Rodríguez C; Rodríguez-Sevilla JJ; Fernández-Ibarrondo L; Sánchez-González B; Gibert J; Bento L; García JF; Sancho JM; Diez-Feijóo R; Camacho L; García-Retortillo M; Gimeno E; Colomo L; Gutiérrez A; Bellosillo B; Salar A
    Blood Adv; 2022 Jan; 6(1):82-86. PubMed ID: 34649275
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. ETV6-NCOA2 fusion induces T/myeloid mixed-phenotype leukemia through transformation of nonthymic hematopoietic progenitor cells.
    Fishman H; Madiwale S; Geron I; Bari V; Van Loocke W; Kirschenbaum Y; Ganmore I; Kugler E; Rein-Gil A; Friedlander G; Schiby G; Birger Y; Strehl S; Soulier J; Knoechel B; Ferrando A; Noy-Lotan S; Nagler A; Mulloy JC; Van Vlierberghe P; Izraeli S
    Blood; 2022 Jan; 139(3):399-412. PubMed ID: 34624096
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. p300/CBP inhibition sensitizes mantle cell lymphoma to PI3Kδ inhibitor idelalisib.
    Zhou XR; Li X; Liao LP; Han J; Huang J; Li JC; Tao HR; Fan SJ; Chen ZF; Li Q; Chen SJ; Ding H; Yang YX; Zhou B; Jiang HL; Chen KX; Zhang YY; Huang CX; Luo C
    Acta Pharmacol Sin; 2022 Feb; 43(2):457-469. PubMed ID: 33850273
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Clonal evolution in diffuse large B-cell lymphoma with central nervous system recurrence.
    Magnes T; Wagner S; Thorner AR; Neureiter D; Klieser E; Rinnerthaler G; Weiss L; Huemer F; Zaborsky N; Steiner M; Weis S; Greil R; Egle A; Melchardt T
    ESMO Open; 2021 Feb; 6(1):100012. PubMed ID: 33399078
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma.
    Zhang P; Zhang M
    Clin Epigenetics; 2020 Nov; 12(1):169. PubMed ID: 33160401
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.